Sorbent Therapeutics, Inc.
750 E. Bunker Court
Suite 900
Vernon Hills
Illinois
60061
United States
Tel: 847-996-1500
Fax: 847-996-1185
Email: JRiddle@SorbentRX.com
10 articles about Sorbent Therapeutics, Inc.
-
Sorbent Therapeutics, Inc. Appoints Two New Board Members
6/18/2014
-
Sorbent Therapeutics, Inc. Closes $15 Million In First Tranche Of Series D
5/15/2014
-
Sorbent Therapeutics, Inc. Appoints Tom O'Neil Chief Financial Officer
1/27/2014
-
Sorbent Therapeutics, Inc. Initiates Phase 2b Clinical Trial of CLP-1001 for Treatment of Signs and Symptoms of Fluid Overload in Patients With Heart Failure
4/11/2013
-
Sorbent Therapeutics, Inc. Presents CLP1001 Phase 2a Study Results at the 16th Annual Meeting of the Heart Failure Society of America
9/11/2012
-
Sorbent Therapeutics, Inc.' CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study
5/22/2012
-
Sorbent Therapeutics, Inc. Announces Additions to Leadership Team
4/19/2012
-
Sorbent Therapeutics, Inc. Completes $36 Million Series B Financing for Net of $53 Million
6/30/2011
-
Sorbent Therapeutics, Inc. Raises $21.8 Million in a Series B Financing Round
9/10/2010
-
Sorbent Therapeutics, Inc. Launches, Takes In $12 Million Series A
2/8/2006